Specific immunotherapy for respiratory allergies;Immunotherapie specifique des allergies respiratoires

Presse Medicale

Volumn 26, Issue 12, 1997, Pages 567-571

  Michel, F B ^a   Bousquet, J ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN;

DRUG EFFICACY; DRUG TOLERANCE; HUMAN; IMMUNOTHERAPY; RESPIRATORY TRACT ALLERGY; REVIEW; DESENSITIZATION; FEMALE; IMMUNOLOGY; MALE; METHODOLOGY;

DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; RESPIRATORY HYPERSENSITIVITY;

EID: 0030925975     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Bousquet J, Michel FB. Safety considerations in assessing the role of immunotherapy in allergic disorders. Drug Saf 1994 ; 10:5-17.
2. Committe on Safety of Medicines. Desensitizing vaccines. Br Med J 1986 ; 293:948.
3. Current status of allergen immunotherapy. Shortened version of a World Health Organisation/International Union of Immunological Societies Working Group Report. Lancet 1989 ; i:259-61.
4. Position paper on allergen immunotherapy. Report of a BSACI working party. January-October 1992. Clin Exp Allergy 1993 ; 3:1-44.
5. Malling H, Weeke B. Immunotherapy. Position Paper of the European Academy of Allergy and Clinical Immunology. Allergy 1993 ; 48(suppl. 14):9-35.
6. Gleich GJ, Zimmermann EM, Henderson LL, Yunginger JW. Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six-year prospective study. J Allergy Clin Immunol 1982 ; 70:261-71.
7. Bousquet J, Maasch H, Martinot B, Hejjaoui A, Wahl R, Michel FB. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy. J Allergy Clin Immunol 1988 ;82:439-46.
8. Golden DB, Meyers DA, Kagey-Sobotka A, Valentine MD, Lichtenstein LM. Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy. J Allergy Clin Immunol 1982 ; 69:489-93.
9. Bousquet J, Becker WM, Hejjaoui et al. Differences in clinical and immunologic reacivity of patients allergic to grass pollens and to multile species. II. Efficacy of a double-blinrd, placebo-controlled, specific immunotherapy with standardized extracts. J Allergy Clin Immunol 1991 ; 88:43-53.
10. Rak S, Lowhagen O, Venge P. The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. J Allergy Clin Immunol 1988 ; 82:470-80.
11. De Vries JE, Carballido JM, Sornasse T, Yssel H. Antagonizing the differentiation and functions of human T helper type 2 cells. Curr Opin Immunol 1995 ; 7:771-8.
12. Varney VA, Hamid QA, Gaga M et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced latephase cutaneous responses. J Clin Invest 1993 ; 92:644-51.
13. Akoum H, Tsicopoulos A, Vorng H et al. Venom immunotherapy modulates interleukin-4 and interferongamma messenger RNA expression of peripheral T lymphocytes. Immunology 1996 ; 87:593-8.
14. Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT, Allergen immunotherapy decreases interleukin 4 production in CD4+T cells from allergic individuals. J Exp Med 1993 ; 178:2123-30.
15. Bousquet J, Michel FB. Specific immunotherapy in asthma: it is effective ? J Allergy Clin Immunol 1994 ; 94:1-11.
16. Bousquet J, Michel F. Immunotherapy in rhinitis. In: Allergic and non-allergic rhinitis, clinical aspects, Mygind N, Naclerio R eds. Munksgaard, Copenhagen 1992:136-48.
17. Malling HJ, Immunotherapy for mold allergy. Clin Rev Allergy 1992 ; 10:237-51.
18. Bousquet J, Hejjaoui A, Dhivert H, Clauzel AM, Michel FB. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. III. Systemic reactions during the rush protocol in patients suffering from asthma. J Allergy Clin Immunol 1989 ; 83:797-802.
19. Global strategy for asthma management and prevention. WHO/NHLBI workshop report. National Institutes of Health, National Heart, Lung and Blood Institute, Publication Number 95-3659, January 1995.
20. Taudorf E. Oral immunotherapy of adults with allergic rhinoconjunctivitis. Clinical in birch and grass pollinosis. Dan Med Bull 1992 ; 39:542-60.
21. Giovane AL, Bardare M, Passalacqua G et al. A three-year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients. Clin Exp Allergy 1994 ; 24:53-9.
22. D'Amato G, Lobefalo G, Liccardi G, Gazzola M. A double-blind, placebo-controlled trial of local nasal immunotherapy in allergic rhinitis to Parietaria pollen. Clin Exp Allergy 1995 ; 25:141-8.
23. Crimi E, Voltolini S, Troise C et al. Local immunotherapy with Dematophagoides extract in asthma. J Allergy Clin Immunol 1991 ; 87:721-8.
24. Moscato G, Rossi G, Dellabianca A, Pisati A, Vinci G, Biale C. Local immunotherapy by inhalation of a powder extract in asthma due to house dust mite Dematophagoides pteronyssinus: a double-blind comparison with parenteral immunotherapy. J Invest Allergol Clin Immunol 1991 ; 1:383-94.
25. Sabbah A, Hassoun S, Le-Sellin J, André C, Sicard H. A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with standardized grass pollen extract. Allergy 1994 ; 49:309-13.
26. Scadding G, Brostoff J. Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite. Clin Allergy 1986; 16:493-9.
27. Reilly D, Taylor M, Beattie N et al. Is evidence for homeopathy reproducible? Lancet 1994 ; 344:1601-6.
28. Cooper PJ, Derbyshire J, Nunn AJ, Warner JO. A controlled trial of oral hyposensitization in pollen asthma and rhinitis in children. Clin Allergy 1984 ; 14:541-50.
29. Taudorf E, Laursen L, Djurup R et al. Oral administration of grass pollen to hay fever patients. An efficacy study of oral hyposensitization. Allergy 1985 ; 40:321-5.
30. Oppenheimer J, Areson JC, Nelson HS. Safety and efficacy of oral immunotherapy with standardized cat extract. J Allergy Clin Immunol 1994 ; 93:61-7.
31. Welsh PW, Butterfield JH, Yunginger JW, Agarwal MK, Gleich GJ. Allergen-controlled study of intranasal immunotherapy for ragweed hay fever. J Allergy Clin Immunol 1983 ; 71:454-60.
32. Nelson H, Oppenheimer J, Vatsia G, Buchmeier A. A double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized cat extract. J Allergy Clin Immunol 1993 ; 92:229-36.
33. Bjorksten B. Local immunotherapy is not documented for clinical use. Allergy 1994 ; 49:299-301.
34. Varney VA, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. B Med J 1991 ; 302:265-9.
35. Bousquet J. Clinical use of recombinant allergens and epitopes.Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 1994 ; 87:257-62.